Germany’s Merck KGaA has agreed to buy SpringWorks Therapeutics, adding the US biotech’s portfolio of cancer and rare disease ...

The health sector is abuzz with significant news: from FDA approvals of novel drugs and mergers like Merck's acquisition of ...